the efficacy and tolerability of diflunisal ( 500 mg orally , twice daily ) and piroxicam ( 20 mg orally , once daily ) were compared in a 12-week open-label study in 44 patients with active rheumatoid arthritis .
C0031990
piroxicam
C0003873
rheumatoid arthritis